Domov › Rakovina (všetky typy) › Utah › Salt Lake City
Klinické štúdie Rakovina (všetky typy) v meste Salt Lake City, UT
27 štúdií pre Rakovina (všetky typy) hľadá účastníkov v zariadeniach v meste Salt Lake City a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Prebieha náborFáza 1/2
- Intermountain - Primary Children's Hospital ( Site 4014), Salt Lake City
SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care
Prebieha nábor
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Prebieha náborFáza 3
- Utah Cancer Specialists Cancer Center - Medical Oncology, Salt Lake City
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Prebieha náborFáza 2
- Intermountain Healthcare, Salt Lake City
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Prebieha náborFáza 2/3
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare - LDS Hospital, Salt Lake City
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Prebieha náborFáza 1/2
- Intermountain - Primary Children's Hospital ( Site 3014), Salt Lake City
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Prebieha náborFáza 2
- Huntsman Cancer Institute - University of Utah Health, Salt Lake City
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Prebieha náborFáza 1/2
- Huntsman Cancer Institute /ID# 271618, Salt Lake City
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Prebieha náborFáza 1/2
- Huntsman Cancer Institute, Salt Lake City
Project: Every Child for Younger Patients With Cancer
Prebieha náborObservačná štúdia
- Primary Children's Hospital, Salt Lake City
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Prebieha náborFáza 3
- University of Utah, Salt Lake City
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Prebieha náborFáza 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Prebieha náborFáza 1/2
- Huntsman Cancer Institute /ID# 272575, Salt Lake City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
Prebieha nábor
- Huntsman Cancer Institute at The University of Utah, Salt Lake City
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Prebieha nábor
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
Prebieha nábor
- University of Utah Huntsman Cancer Institute (HCI), Salt Lake City
- University of Utah Primary Children's Hospital, Salt Lake City
Galleri® in the Medicare Population.
Prebieha náborVítaní zdravých dobrovoľníkov
- HCA Healthcare St. Marks, Salt Lake City
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Prebieha náborFáza 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Prebieha nábor
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Improving Health Insurance Literacy Among Young Adult Cancer Survivors
Prebieha nábor
- University of Utah, Salt Lake City
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Prebieha náborFáza 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
Prebieha nábor
- Huntsman Cancer Institute, Salt Lake City
Childhood Cancer Predisposition Study (CCPS)
Prebieha náborObservačná štúdia
- Primary Children's Hospital, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Salt Lake City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Prebieha náborObservačná štúdia
- Utah Cancer Specialists, Salt Lake City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Prebieha nábor
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
Štúdie Rakovina (všetky typy) v iných mestách
- Houston, TX121 štúdií
- New York City, NY109 štúdií
- Boston, MA85 štúdií
- Los Angeles, CA74 štúdií
- Nashville, TN65 štúdií
- Philadelphia, PA59 štúdií
- Washington, DC58 štúdií
- Durham, NC58 štúdií
- Chicago, IL51 štúdií
- Atlanta, GA49 štúdií
- Seattle, WA49 štúdií
- Arlington, VA48 štúdií
Iné štúdie v Salt Lake City
- Nemalobunkový karcinóm pľúc31 štúdií
- Rakovina prsníka27 štúdií
- Kolorektálny karcinóm22 štúdií
- Rakovina pľúc21 štúdií
- Melanóm21 štúdií
- Mnohonásobný myelóm21 štúdií
- Metastatická rakovina20 štúdií
- Rakovina vaječníkov19 štúdií
- Obézita18 štúdií
- Akútna myeloidná leukémia17 štúdií
- Srdcové zlyhanie17 štúdií
- Rakovina prostaty15 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.